Author's reply to Letter to the Editor. We thank Favell et al. for their interest in our Brief Report, Capture of systemic anticancer therapy use by routinely collected health datasets (2020;30(1):e3012004).1
Bibliographical noteThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Licence, which allows others to redistribute, adapt and share this work non-commercially provided they attribute the work and any adapted version of it is distributed under the same Creative Commons licence terms.
- anticancer agents
- Pharmaceutical Benefits Scheme (PBS)